Science Press Releases
SEE OTHER BRANDS

Informing on science news in the world

Science Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science Press Releases.

Press releases published on May 12, 2025

Iron-based nanoparticles in agriculture: promise, peril, or paradox?

Iron-based nanoparticles in agriculture: promise, peril, or paradox?

GA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- A sweeping new analysis unpacks the complex role of iron-based nanoparticles (Fe-NPs) in agriculture, revealing a delicate balance between benefit and risk. Synthesizing findings from 57 peer-reviewed …

Tiny titans at high elevations: how soil microbes sustain forest resilience

Tiny titans at high elevations: how soil microbes sustain forest resilience

GA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- High-altitude forest soils host microscopic communities with outsized influence on ecosystem stability. A recent study unveiled how microbial sub-communities—generalists, intermediates, and …

CMTA-INC Alliance Announces 2025 Inherited Neuropathy Fellowship Recipient

CMTA-INC Alliance Announces 2025 Inherited Neuropathy Fellowship Recipient

Orthopedic Surgeon to Focus on Improving Outcomes for People with CMT GLENOLDEN, PA, UNITED STATES, May 12, 2025 /⁨EINPresswire.com⁩/ -- The Charcot-Marie-Tooth Association (CMTA), the largest philanthropic funder of Charcot-Marie-Tooth disease (CMT) …

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

ANI Pharmaceuticals to Participate at the H.C. Wainwright 3rd Annual BioConnect Conference at NASDAQ

PRINCETON, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the H.C. Wainwright …

The EDR Test That Matters - AV-Comparatives to publish the first truly stealth-based EDR test

The EDR Test That Matters - AV-Comparatives to publish the first truly stealth-based EDR test

AV-Comparatives to publish the first truly stealth-based EDR test at the end of May, exposing how today’s security tools fare against APT cyberattacks. INNSBRUCK, TYROL, AUSTRIA, May 12, 2025 /⁨EINPresswire.com⁩/ -- AV-Comparatives, the world-renowned …

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

Apimeds Pharmaceuticals US, Inc. Announces Closing of Initial Public Offering

Hopewell, New Jersey, May 12, 2025 (GLOBE NEWSWIRE) -- Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) (“Apimeds” or the “Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally …

AV-Comparatives Publishes New Consumer Cybersecurity Antivirus Test Results – May 2025

AV-Comparatives Publishes New Consumer Cybersecurity Antivirus Test Results – May 2025

Latest Evaluations Reveal Which Cybersecurity and Antivirus Programs Truly Protect – Without Slowing You Down INNSBRUCK, TYROL, AUSTRIA, May 12, 2025 /⁨EINPresswire.com⁩/ -- In a time when cyberattacks are on the rise and personal data is more valuable …

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend

Constellation Software Inc. Announces Results for the First Quarter Ended March 31, 2025 and Declares Quarterly Dividend

TORONTO, May 12, 2025 (GLOBE NEWSWIRE) -- Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the first quarter ended March 31, 2025 and declared a $1.00 per share dividend payable on July 11, …

Microvast Reports First Quarter 2025 Financial Results

Microvast Reports First Quarter 2025 Financial Results

Record company Q1 revenue, increased 43.2% year over year to $116.5 million Gross margin increased from 21.2% to 36.9%, a 15.7 percentage point improvement year over year STAFFORD, Texas, May 12, 2025 (GLOBE NEWSWIRE) -- Microvast Holdings, Inc. (NASDAQ: …

3D Systems Reports First Quarter 2025 Financial Results

3D Systems Reports First Quarter 2025 Financial Results

ROCK HILL, S.C., May 12, 2025 (GLOBE NEWSWIRE) -- 3D Systems Corporation (NYSE:DDD) announced today its financial results for the first quarter ended March 31, 2025. Revenue of $95 million as growth in new hardware systems and related services was offset …

AirJoule Technologies Announces First Quarter 2025 Results

AirJoule Technologies Announces First Quarter 2025 Results

RONAN, Mont., May 12, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), the developer of the transformational AirJoule® system for separating pure water from air, today announced its first …

 New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

New 4-Year Data Shows Sustained Response to TransCon® PTH (Palopegteriparatide) Therapy in Adults with Hypoparathyroidism

COPENHAGEN, Denmark, May 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with TransCon PTH (palopegteriparatide) continued to provide …

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, May 12, 2025 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context …

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update

BeyondSpring Reports First‑Quarter 2025 Financial Results and Provides Corporate Update

Presentation at IO 360° conference showed early efficacy for Plinabulin combinations in metastatic NSCLC and Hodgkin lymphoma resistant to PD‑1/L1 therapy SEED’s first‑in‑class RBM39 degrader, reported at AACR 2025 for its total tumor regression data in …

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

Tonix Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Highlights

FDA PDUFA goal date of August 15, 2025, for TNX-102 SL for the management of fibromyalgia; if approved, TNX-102 SL would become the first new drug for treating fibromyalgia in more than 15 years Announced positive topline results from Phase 1 study of TNX- …

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

MORRISTOWN, N.J., May 12, 2025 (GLOBE NEWSWIRE) -- Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company that had been developing a treatment for non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and …

Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer

Satellogic Secures Multi-Million Dollar Agreement with Asia Pacific Customer

DAVIDSON, N.C., May 12, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, announced today it has entered into a multi-million dollar agreement with an Asia Pacific customer. The agreement provides …

Cellectis Reports Financial Results for the First Quarter 2025

Cellectis Reports Financial Results for the First Quarter 2025

Lasme-cel (UCART22) Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025 Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r NHL) ongoing with readout expected in late 2025 …

Editas Medicine Announces First Quarter 2025 Results and Business Updates

Editas Medicine Announces First Quarter 2025 Results and Business Updates

Company to share in vivo preclinical data demonstrating the successful use of targeted lipid nanoparticles to deliver HBG1/2 promoter editing cargo to hematopoietic stem and progenitor cells (HSPCs) at ASGCT this week Company will also share in vivo …

Life360 Reports Record Q1 2025 Results

Life360 Reports Record Q1 2025 Results

Monthly Active Users Reached Approximately 83.7 million Record Q1 Global Net Additions to Paying Circles of 137 thousand - Reaching 2.4 million Total Total Quarterly Revenue Grew 32% Year-Over-Year to $103.6 million Annualized Monthly Revenue increased 38% …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service